Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, Pradhan K, Thota R, Reissman S, Sparano JA, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020;26(8):1218–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2021;7(2):220–7.

Article  PubMed  Google Scholar 

Chakravarty D, Ratnani P, Sobotka S, Lundon D, Wiklund P, Nair SS, Tewari AK: Increased hospitalization and mortality from COVID-19 in prostate cancer patients. Cancers (Basel). 2021;13(7).

Ruthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Gruner B, Hanses F, Isberner N, Kohler P, Lanznaster J, et al. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry. Ann Hematol. 2021;100(2):383–93.

Article  PubMed  Google Scholar 

Al-Quteimat OM, Amer AM. The impact of the COVID-19 pandemic on cancer patients. Am J Clin Oncol. 2020;43(6):452–5.

Article  CAS  PubMed  Google Scholar 

Jones JM, Saeed H, Katz MS, Lustberg MB, Forster VJ, Nekhlyudov L. Readdressing the needs of cancer survivors during COVID-19: a path forward. J Natl Cancer Inst. 2021;113(8):955–61.

Article  PubMed  Google Scholar 

Xie Z, Saliba AN, Abeykoon J, Majeed U, Almquist DR, Wiedmeier-Nutor JE, Bezerra E, Andrade-Gonzalez X, Hickman A, Sorenson K, et al. Outcomes of COVID-19 in patients with cancer: a closer look at pre-emptive routine screening strategies. JCO Oncol Pract. 2021;17(9):e1382–93.

Article  PubMed  PubMed Central  Google Scholar 

Akingboye A, Mahmood F, Amiruddin N, Reay M, Nightingale P, Ogunwobi OO. Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study. BMJ Open. 2021;11(12):e053352.

Article  PubMed  Google Scholar 

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5).

Peravali M, Joshi I, Ahn J, Kim C. A systematic review and meta-analysis of clinical characteristics and outcomes in patients with lung cancer with coronavirus disease 2019. JTO Clin Res Rep. 2021;2(3):100141.

PubMed  PubMed Central  Google Scholar 

Sun L, Surya S, Le AN, Desai H, Doucette A, Gabriel P, Ritchie MD, Rader D, Maillard I, Bange E, et al. Rates of COVID-19-related outcomes in cancer compared with noncancer patients. JNCI Cancer Spectr. 2021;5(1):pkaa120.

Article  PubMed  PubMed Central  Google Scholar 

Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rivera DR, Peters S, Panagiotou OA, Shah DP, Kuderer NM, Hsu CY, Rubinstein SM, Lee BJ, Choueiri TK, de Lima Lopes G Jr, et al. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and cancer consortium (CCC19) cohort study. Cancer Discov. 2020;10(10):1514–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):904–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan. China JAMA Oncol. 2020;6(7):1108–10.

Article  PubMed  Google Scholar 

Zarifkar P, Kamath A, Robinson C, Morgulchik N, Shah SFH, Cheng TKM, Dominic C, Fehintola AO, Bhalla G, Ahillan T, et al. Clinical characteristics and outcomes in patients with COVID-19 and cancer: a systematic review and meta-analysis. Clin Oncol (R Coll Radiol). 2021;33(3):e180–91.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan. China Ann Oncol. 2020;31(7):894–901.

Article  CAS  PubMed  Google Scholar 

Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020;31(8):1088–9.

Article  CAS  PubMed  Google Scholar 

Li Q, Chen L, Li Q, He W, Yu J, Chen L, Cao Y, Chen W, Di W, Dong F, et al. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission. Leukemia. 2020;34(9):2384–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao F, Henderson TO, Cipriano TM, Copley BL, Liu M, Burra R, Birch SH, Olopade OI, Huo D. The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort. Cancer. 2021;127(21):4072–80.

Article  CAS  PubMed  Google Scholar 

Jammu AS, Chasen MR, Lofters AK, Bhargava R. Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020. Support Care Cancer. 2021;29(6):2841–50.

Article  PubMed  Google Scholar 

Kullar R, Marcelin JR, Swartz TH, Piggott DA, Macias Gil R, Mathew TA, Tan T. Racial disparity of coronavirus disease 2019 in African American Communities. J Infect Dis. 2020;222(6):890–3.

Article  CAS  PubMed  Google Scholar 

Tirupathi R, Muradova V, Shekhar R, Salim SA, Al-Tawfiq JA, Palabindala V. COVID-19 disparity among racial and ethnic minorities in the US: a cross sectional analysis. Travel Med Infect Dis. 2020;38:101904.

Article  PubMed  PubMed Central  Google Scholar 

Mangone L, Gioia F, Mancuso P, Bisceglia I, Ottone M, Vicentini M, Pinto C, Giorgi Rossi P. Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: a population-based study in Reggio Emilia. Northern Italy Int J Cancer. 2021;149(4):820–6.

Article  CAS  PubMed  Google Scholar 

Ramachandran P, Kathirvelu B, Chakraborti A, Gajendran M, Zhahid U, Ghanta S, Onukogu I, Narh JT, Wang JC, Anwer F. COVID-19 in cancer patients from New York City: a comparative single center retrospective analysis. Cancer Control. 2020;27(1):1073274820960457.

Article  PubMed  PubMed Central  Google Scholar 

Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edge R, Mazariego C, Li Z, Canfell K, Miller A, Koczwara B, Shaw J, Taylor N. Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services. Support Care Cancer. 2021;29(9):5463–73.

Article  PubMed  PubMed Central  Google Scholar 

Baddour K, Kudrick LD, Neopaney A, Sabik LM, Peddada SD, Nilsen ML, Johnson JT, Ferris RL, Mady LJ. Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors. Head Neck. 2020;42(6):1332–8.

Article  PubMed  PubMed Central  Google Scholar 

Haque R, Chen L. SARS-CoV-2 testing, positivity rates, and healthcare outcomes in a cohort of 22,481 breast cancer survivors. JCO Clin Cancer Inform. 2021;5:168–75.

Article  PubMed  Google Scholar 

Cantor D, Coa K, Crystal-Mansour S, Davis T, Dipko S, Sigman R. Health information trends survey (HINTS) 2007: final report. In.; 2007.

Nelson DE, Kreps GL, Hesse BW, Croyle RT, Willis G, Arora NK, Rimer BK, Viswanath KV, Weinstein N, Alden S. The health information national trends survey (HINTS): development; design, and dissemination. J Health Commun. 2004;9(5):443–60.

Article